This week's applied chemistry & life

[Andrew M Smith]

This week, www.selectscience.net reported
                on 20 news stories the day they
happened,
                so if you need to keep up to speed on
                the latest business developments in
                chemistry and life science, make the
news
                ticker on www.selectscience.net part
of
                your daily routine.

                Andrew Smith
(andrew at selectscience.net)
                Editor, www.selectscience.net

                This week's headlines were:

                PE Biosystems Stock To Split
Two-For-One

                QIAGEN N.V. Annual Report 1998

                Neurogen Licenses AIDD(SM) Technology
to Pfizer for $27 Million

                Bio-Rad Laboratories Announces Its
Offer for Pasteur Sanofi Diagnostics

                Vysis and Eos Join Forces to Identify
New Markers of Breast Cancer

                Cytogen and Progenics Announce Joint
Venture to Collaborate on Prostate
                Cancer Immunotherapeutics

                Pharmacia & Upjohn Announces Agreement
With Sensus Drug Development
                Corporation

                OXiGENE and Active Biotech Enter
Research Collaboration to Develop
                Anti-Inflammatory Therapeutics

                Invitrogen Corporation and NOVEX Sign
Definitive Agreement to Merge

                Aurora Biosciences Announces Issuance
of First U.S. Patent For NanoWell
                Assay Plate

                Celltech plc merger with Chiroscience
Group plc

                SEC Registration Filed for Genentech
Public Offering

                Abbott Laboratories Declares 302nd
Consecutive Quarterly Dividend

                Chevron Chemical Co. Sells Part of
Specialty Polymers Business

                Academic Researchers and Industry
Associations Agree Reports on Bt Crop
                Impact on Monarch Butterflies
Overblown

                Biogen Announces 2-for-1 Stock Split

                Genomics Partnership between Organon &
Incyte Extended

                Isco Reports Third Quarter Fiscal 1999
Results

                BioChem Pharma Announces Agreement in
Principle to Purchase 8 Million
                BioChem Common Shares from Glaxo
Wellcome Inc.

                Amersham Pharmacia Biotech Signs Two
Major Mass Spec/Proteomics Deals




===



Moderated
bionet.genome.gene-structure


_________________________________________________________
Do You Yahoo!?
Get your free @yahoo.com address at http://mail.yahoo.com